当归多糖对实验性糖尿病大鼠糖代谢的影响及其机制被引量：4

On Effects and Mechanism of Angelica Sinensis Polysaccharides on Glucose Metabolism in Experimental Diabetic Rats

导出

摘要研究当归多糖(ASP)对实验性糖尿病大鼠糖代谢的影响,探讨ASP对实验性糖尿病大鼠的降糖机制。制备实验性糖尿病大鼠40只,随机分成4组,分别用生理盐水、低剂量ASP(20mg.kg-1)、高剂量ASP(100mg.kg-1)以及盐酸二甲双胍(150mg.kg-1)灌胃给药,每日1次,连续21天。同时采用正常大鼠为健康对照,观察ASP对实验性糖尿病大鼠空腹血糖、血浆胰岛素、胰岛素敏感性指数、肝糖原等指标的影响。发现ASP能明显的降低糖尿病大鼠的血糖,其机制可能与其促进胰岛B细胞修复和再生有关,提示ASP有作为口服降糖药辅助用药的可能性。 the paper presents the research on the effects of Angelica Sinensis Polysaccharides（ASP） on glucose metabolism in experimental diabetic rats,which leads to the finding of the mechanism of hypoglycaemic effect of ASP.Treated with ASP,FPG was reduced and Ins and hepatin were increased,respectively,as compared with model group.Conclusion ASP can obviously lower blood sugar,which may be associated with the promoting the repair and regeneration of the damaged islet B cell.The results suggest that ASP has the possibility to be used as an adjuvant drug of oral hypoglycemic agents.

作者陈洁

机构地区武汉职业技术学院生物工程学院

出处《武汉职业技术学院学报》 2010年第3期93-95,共3页 Journal of Wuhan Polytechnic

基金武汉职业技术学院2008年立项科研课题"当归多糖的分离纯化与鉴定及其对肝损伤的干预作用"(项目编号:2008YK267)

关键词当归多糖四氧嘧啶糖代谢 angelica sinensis polysaccharides alloxan glucose metabolism

分类号 R349.64 [医药卫生—基础医学]

引文网络
相关文献

参考文献7

1LEVETAN C. Oral antidiabetic agents in type 2 diabetes [J]. Curr Med Res Opin,2007,23(4): 945-952.
2郑敏,王亚平.当归多糖对人髓系多向造血祖细胞增殖分化的影响及其机理研究[J].解剖学杂志,2002,25(2):105-109. 被引量：53
3YE Y N,SO H L. Effect of polysaccharides from Angelica sinensis on gastric ulcer healing[ J ]. Life Sci, 2003,72 (8): 925-932.
4林志彬. 抗糖尿病药物实验法[A]. 见:徐叔云,卞如濂,陈修,主编. 药理实验方法学[M]. 第3版. 北京:人民卫生出版社,2002: 1516-29
5叶菲.糖原合成与糖异生测定[A].见:张均田,主编.现代药理实验方法[M].第1版.北京:北京医科大学中国协医科大学联合出版社,1998:1006-8
6孙素娟,申竹芳,陈跃腾,唐玲,丁世英,谢明智.结合亚油酸对胰岛素抵抗模型MSG肥胖小鼠的影响[J].药学学报,2003,38(12):904-907. 被引量：15
7崔福生.医学生化检验手册[M].天津：天津科学技术出版社,1981.272-273.

二级参考文献12

1王亚平,祝彼得.当归多糖对造血祖细胞增殖调控机理的研究[J].中华医学杂志,1996,76(5):363-366. 被引量：50
2[1]Lin H, Boylston TD, Chang MJ, et al. Survey of the conjugated linoleic acid contents of dairy products [J]. J Dairy Sci, 1995,78(11):2358-2365.
3[2]Ostrowska E, Muralitharan M, Cross RF, et al. Dietary conjugated linoleic acids increase lean tissue and decrease fat deposition in growing pigs [J]. J Nutr, 1999,129(11):2037-2042.
4[3]Park Y, Albright KJ, Liu W, et al. Effect of conjugated linoleic acid on body composition in mice [J]. Lipids, 1997,32(8):853-858.
5[4]Deckere EAM, Amelsvoort JMM, McNeil GP, et al. Effect of conjugated linoleic acid (CLA) isomers on lipid levels and peroxisome proliferation in the hamster [J]. Br J Nutr, 1999,82(4):309-317.
6[5]Karen LH, John PVH, Silvia YMC, et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the zucker diabetic fatty fa/fa rat [J]. Biochem Biophys Research Commun, 1998,244(3):678-682.
7[6]Song GM, Tang L, Sun SJ, et al. Partial characterization of insulin resistance in monosodium L-glutamate (MSG)-treated obese mice [J]. Diabetes, Obes Metab, (in press).
8[7]Nobuyo TK, Mayumi T, Kentaro T, et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice [J]. Diabetes, 2000,49(9),1534-1542.
9[8]Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance [J]. Science, 1993,259(1):87-91.
10[9]Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor-αin human adipose tissue [J]. J Clin Invest, 1995,95(5):2111-2115.